European Journal of Medicinal Chemistry, Год журнала: 2024, Номер 284, С. 117202 - 117202
Опубликована: Дек. 26, 2024
Язык: Английский
European Journal of Medicinal Chemistry, Год журнала: 2024, Номер 284, С. 117202 - 117202
Опубликована: Дек. 26, 2024
Язык: Английский
ACS Medicinal Chemistry Letters, Год журнала: 2024, Номер 15(6), С. 791 - 797
Опубликована: Май 20, 2024
Bfl-1 is overexpressed in both hematological and solid tumors; therefore, inhibitors of are highly desirable. A DNA-encoded chemical library (DEL) screen against identified the first known reversible covalent small-molecule ligand for Bfl-1. The binding was validated through biophysical biochemical techniques, which confirmed mechanism action pointed to Cys55. This represented identification a cyano-acrylamide compound from DEL highlights further opportunities drug discovery screening. 10-fold improvement potency achieved systematic SAR exploration hit. more potent analogue
Язык: Английский
Процитировано
4ACS Medicinal Chemistry Letters, Год журнала: 2025, Номер 16(4), С. 693 - 699
Опубликована: Март 19, 2025
Most ligands for the Von Hippel-Lindau tumor suppressor (VHL) bind at HIF-1α binding site. Ligands that to allosteric sites on VHL could be highly valuable field of protein degradation, therefore, a covalent hit identification campaign was run targeting Cys77 VHL. Hit 2 bound selectively and did not alkylate reactive Cys89 Elongin B. It showed time- concentration-dependent labeling, with k inact/K I 0.30 M-1 s-1, does affect This ligand optimized afford compound 15 which improved potency labeling An X-ray structure close analogue determined revealing in shallow groove surface These are first small molecules covalently an site provide suitable starting point further optimization.
Язык: Английский
Процитировано
0ChemistryOpen, Год журнала: 2025, Номер unknown
Опубликована: Апрель 16, 2025
Covalent approaches have resurged in drug discovery and chemical biology during the last decade. So‐called targeted covalent inhibitors typically show a strong persistent drug–target interaction as well high degree of selectivity. In our research group, RMS‐07 (8) , First‐in‐Class inhibitor protein kinase threonine tyrosine (TTK)/monopolar spindle 1, which shows promising results variety different solid cancer cell types will be further optimized terms binding kinetics, has recently been developed. However, synthetic accessibility is restricted by price limited availability [1‐(ethoxycarbonyl)cyclopropyl] triphenylphosphonium tetrafluoroborate ( 10 ), key reagent required to assemble tricyclic core scaffold Wittig‐type cyclization reaction. This also described valuable synthon for synthesis range ring systems with interesting applications medicinal chemistry. reliable procedures its large‐scale are scarce. Only one prior report describes it contains experimental details, making challenging reproduce scale up. Herein, concise reproducible decigram‐scale protocol accessing described.
Язык: Английский
Процитировано
0Journal of Medicinal Chemistry, Год журнала: 2024, Номер 67(13), С. 11209 - 11225
Опубликована: Июнь 25, 2024
Covalent hit identification is a viable approach to identify chemical starting points against difficult-to-drug targets. While most researchers screen libraries of <2k electrophilic fragments, focusing on lead-like compounds can be advantageous in terms finding hits with improved affinity and better chance identifying cryptic pockets. However, due the increased molecular complexity, larger numbers (>10k) are desirable ensure adequate coverage space. Herein, taken build library 12k covalent reported, utilizing legacy compounds, robust chemistry, acquisitions. The was screened antiapoptotic protein Bfl-1, six promising that displaced BIM peptide from PPI interface were identified. Intriguingly, X-ray crystallography compound
Язык: Английский
Процитировано
3Drug Discovery Today, Год журнала: 2024, Номер 29(10), С. 104143 - 104143
Опубликована: Авг. 23, 2024
Язык: Английский
Процитировано
2SLAS TECHNOLOGY, Год журнала: 2024, Номер unknown, С. 100216 - 100216
Опубликована: Окт. 1, 2024
Tracking chemical reactions by measuring incurred mass shifts upon successful binding is a direct and attractive alternative to existing assays based on tags. Traditional methods use liquid chromatography-mass spectrometry (LC-MS), because the required buffers are not amenable MS injection, sample pre-treatment needed desalt. This leads analysis times from ten seconds minutes per sample, limiting throughput preventing widespread application. Combining an acoustic ejection (AE) interface with time-of-flight spectrometer (MS) removes this bottleneck, as samples can be directly introduced at rates of up one second sample. article describes complete workflow for covalent compounds proteins in real-time, assay data evaluation. It noteworthy that first instance using SCIEX Echo® MS+ system ZenoTOF 7600 study kinetic regimes binding.
Язык: Английский
Процитировано
1European Journal of Medicinal Chemistry, Год журнала: 2024, Номер 284, С. 117202 - 117202
Опубликована: Дек. 26, 2024
Язык: Английский
Процитировано
0